Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies

Cited by (410)

Items 101–200 of 410

1. Complex regulation of γ-secretase: from obligatory to modulatory subunits
   Natalya Gertsik, Danica Chiu, Yue‐Ming Li · 2015 · Frontiers in Aging Neuroscience
2. HSP90 Inhibitor 17-AAG Selectively Eradicates Lymphoma Stem Cells
   Bryan W. Newman, Yan Liu, Hsiu-Fang Lee, Duxin Sun, Yin Wang · 2012 · Cancer Research
3. Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
   Clément Larrue, Nathan Guiraud, Pierre‐Luc Mouchel, Marine Dubois, Thomas Farge, Mathilde Gotanègre, Claudie Bosc, Estelle Saland, Marie-Laure Nicolau-Travers, Marie Sabatier et al. · 2021 · Nature Communications
4. Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
   Jialan Niu, Danyue Peng, Lingbo Liu · 2022 · Frontiers in Oncology
5. Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: in vitro anti-proliferative and anti-invasive activity in glioblastoma
   Walhan Alshaer, Manar Saleh Zraikat, Amer Amer, Hamdi Nsairat, Zainab Lafi, Dana A. Alqudah, Enas Al Qadi, Tasneem Alsheleh, Fadwa Odeh, Arwa Alkaraki et al. · 2019 · RSC Advances
6. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways
   Ohad Oren, Benjamin D. Smith · 2016 · Stem Cell Reviews and Reports
7. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin
   Gong Peng, Yin Wang, Pengfei Ge, Christopher M. Bailey, Peng Zhang, Di Zhang, Zhaoli Meng, Chong Qi, Qian Chen, Jingtao Chen et al. · 2021 · Journal of Experimental & Clinical Cancer Research
8. The cardiac hypoxic niche: emerging role of hypoxic microenvironment in cardiac progenitors.
   Wataru Kimura, Hesham A. Sadek · 2012 · Europe PMC (PubMed Central)
9. Metabolic Imaging Reveals a Unique Preference of Symmetric Cell Division and Homing of Leukemia-Initiating Cells in an Endosteal Niche.
   Xiaoxin Hao, Hao Gu, Chi-Qi Chen, Dan Huang, Yu-Zheng Zhao, Li Xie, Ye-Jun Zou, Hui Sophie Shu, Yaping Zhang, Xiao-Xiao He et al. · 2019 · Cell Metabolism
10. Nrf2 and HIF1α converge to arsenic-induced metabolic reprogramming and the formation of the cancer stem-like cells
    Zhuoyue Bi, Qian Zhang, Yao Shi Fu, Priya Wadgaonkar, Wenxuan Zhang, Bandar Saeed Almutairy, Liping Xu, M’Kya Rice, Yiran Qiu, Chitra Thakur et al. · 2020 · Theranostics
11. Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma
    Shaobo Wang, Yanhua Qi, Xiao Chan Gao, Wei Qiu, Qinglin Liu, Xiaofan Guo, Mingyu Qian, Zihang Chen, Zongpu Zhang, Huizhi Wang et al. · 2020 · Cell Death and Disease
12. HIF-1α deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency
    Jinwei Du, Yu Chen, Qiang Li, Xiangzi Han, Cindy Cheng, Zhengqi Wang, David Danielpour, Sally L. Dunwoodie, Kevin D. Bunting, Yu‐Chung Yang · 2012 · Blood
13. Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting
    Qianqian Guo, Yi Zhou, Tianyuan Xie, Yuan Yin, Huilong Li, Wanjin Shi, Lufeng Zheng, Xiaoman Li, Wenzhou Zhang · 2023 · Genes & Diseases
14. Extinguishing the Embers: Targeting AML Metabolism
    Rachel Culp‐Hill, Angelo D’Alessandro, Eric Martin Pietras · 2020 · Trends in Molecular Medicine
15. Type 3 Deiodinase: Role in Cancer Growth, Stemness, and Metabolism
    Domenico Ciavardelli, Maria Bellomo, Caterina Crescimanno, Veronica Vella · 2014 · Frontiers in Endocrinology
16. The Role of Hypoxia and Exploitation of the Hypoxic Environment in Hematologic Malignancies
    Barbara Muz, Pilar de la Puente, Feda Azab, Micah John Luderer, Abdel Kareem Azab · 2014 · Molecular Cancer Research
17. Cell signaling pathways as molecular targets to eliminate AML stem cells
    Ana Carolina Rodrigues, Rafaela G.A. Costa, Suellen L. R. Silva, Ingrid R. S. B. Dias, Rosane B. Dias, Daniel Pereira Bezerra · 2021 · Critical Reviews in Oncology/Hematology
18. Targeting CSCs in Tumor Microenvironment: The Potential Role of ROS-Associated miRNAs in Tumor Aggressiveness
    Bin Bao, Asfar Sohail Azmi, Yiwei Li, Aamir Ahmad, Shadan S. Ali, Sanjeev Banerjee, Dejuan Kong, Fazlul H. Sarkar · 2013 · Current Stem Cell Research & Therapy
19. Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment
    Hui‐Lu Zhang, Ming-Da Wang, Xu Zhou, Chen‐Jie Qin, Gongbo Fu, Liang Tang, Han Wu, Shuai Huang, Linghao Zhao, Min Zeng et al. · 2016 · Cancer Letters
20. From stem cells to cancer stem cells: HIF takes the stage
    Kyoung Eun Lee, Marie Celeste Simon · 2012 · Current Opinion in Cell Biology
21. Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment
    Muhammad Zaeem Noman, Yosra Messai, Jane C. Muret, Meriem Hasmim, Salem Chouaı̈b · 2014 · Cancer Microenvironment
22. Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway?
    H. Fazilaty, M. Gardaneh, Tayyeb Bahrami, Arash Salmaninejad, B. Behnam · 2013 · Tumor Biology
23. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling
    Dorian Forte, Valentina Salvestrini, Giulia Corradi · 2016 · Oncotarget
24. IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer
    Dong Wang, Jiahui Xu, Bingjie Liu, Xueyan He, Lei Zhou, Xin Hu, Feng Qiao, Anli Zhang, Xiaojun Xu, Huafeng Zhang et al. · 2017 · Cell Death and Differentiation
25. Bacteria as a double-action sword in cancer
    Atieh Yaghoubi, Majid Khazaei, Saba Jalili, Seyed Mahdi Hasanian, Amir Avan, Saman Soleimanpour, William Chi Shing Cho · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
26. High Concentrations of L-Ascorbic Acid Specifically Inhibit the Growth of Human Leukemic Cells via Downregulation of HIF-1α Transcription
    Kawada, Hiroshi, Kaneko, Mitsuyo, Sawanobori, Masakazu, Uno, Tomoko, Matsuzawa, Hideyuki, Nakamura, Yoshihiko, Matsushita, Hiromichi, Ando, Kiyoshi · 2013 · PLoS ONE
27. Aptamer-functionalized pH-sensitive liposomes for a selective delivery of echinomycin into cancer cells
    Zainab M. Lafi, Walhan Alshaer, Ma’mon M. Hatmal, Malek A. Zihlif, Dana A. Alqudah, Hamdi Nsairat, Hanan Azzam, Talal A. Aburjai, Yasser Khalil Bustanji, Abdalla Awidi · 2021 · RSC Advances
28. Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
    Alexandre Teixeira Vessoni, Eduardo Cremonese Filippi‐Chiela, Guido Lenz, Luís F.Z. Batista · 2019 · Oncogene
29. Targeting hypoxia in solid and haematological malignancies
    Bill Harris, Sana Saleem, Natalie Cook, Emma J Searle · 2022 · Journal of Experimental & Clinical Cancer Research
30. Hypoxia and HIFs in regulating the development of the hematopoietic system
    Parisa Imanirad, Elaine Anne Dzierzak · 2013 · Blood Cells Molecules and Diseases
31. Overexpression of HIF-1a could partially protect K562 cells from 1,4-benzoquinone induced toxicity by inhibiting ROS, apoptosis and enhancing glycolysis
    Rongli Sun, Xing Meng, Yunqiu Pu, Fengxia Sun, Zhaodi Man, Juan Zhang, Lihong Yin, Yuepu Pu · 2018 · Toxicology in Vitro
32. Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia
    Martyna Śniegocka, Francesca Liccardo, Francesco Fazi, Silvia Masciarelli · 2022 · Drug Resistance Updates
33. The biomarkers of leukemia stem cells in acute myeloid leukemia
    Yahui Ding, Huier Gao, Quan Zhang · 2017 · Stem Cell Investigation
34. Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes
    Yoshihiro Hayashi, Yue Zhang, Asumi Yokota, Xiaomei Yan, Jinqin Liu, Kwangmin Choi, Bing Li, Goro Sashida, Yanyan Peng, Zefeng Xu et al. · 2018 · Cancer Discovery
35. 3D chromatin architecture and epigenetic regulation in cancer stem cells
    Yuliang Feng, Xingguo Liu, Siim Pauklin · 2021 · Protein & Cell
36. Acute myelogenous leukemia stem cells: From Bench to Bedside
    Juan Felipe Rico, Duane C. Hassane, Mónica L. Guzmán · 2012 · Cancer Letters
37. RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment
    Shi Chen, Jiaqiang Zhang, Jiangzhi Chen, Yaodong Wang, Songqiang Zhou, Long Huang, Yannan Bai, Chenghong Peng, Baiyong Shen, Huixing Chen et al. · 2019 · Journal of Experimental & Clinical Cancer Research
38. Elucidating minimal residual disease of paediatric B-cell acute lymphoblastic leukaemia by single-cell analysis
    Yingchi Zhang, Shicheng Wang, Jingliao Zhang, Chao Liu, Xinqi Li, Wenbo Guo, Yong-Juan Duan, Xiaoyan Chen, Su-Yu Zong, Jiarui Zheng et al. · 2022 · Nature Cell Biology
39. HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress
    Rashim Pal Singh, Kristin Franke, Joanna Maria Kalucka, Soulafa Mamlouk, Antje Muschter, Agnieszka Gembarska, Tatyana Grinenko, Carsten Willam, Ronald Naumann, Konstantinos Anastassiadis et al. · 2013 · Blood
40. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells
    Bin Bao, Aamir Ahmad, Yiwei Li, Asfar Sohail Azmi, Shadan S. Ali, Sanjeev Banerjee, Dejuan Kong, Fazlul H. Sarkar · 2012 · Expert Opinion on Therapeutic Targets
41. HIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia
    Nana Zhe, Shu-Ya Chen, Zheng Zhou, Ping Liu, Xiao-Jing Lin, Mei-Sheng Yu, Bing-Qing Cheng, Ya-Ming Zhang, Ji-Shi Wang · 2016 · Cancer Biology & Therapy
42. Roles of the hypoxia response system in hematopoietic and leukemic stem cells
    Keiyo Takubo, Toshio Suda · 2012 · International Journal of Hematology
43. Hypoxia Pathway Proteins in Normal and Malignant Hematopoiesis
    Ben Wielockx, Tatyana Grinenko, Peter Mirtschink, Triantafyllos Chavakis · 2019 · Cells
44. Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer
    Bailey, Christopher M., Liu, Yan, Peng, Gong, Zhang, Huixia, He, Miao, Sun, Duxin, Zheng, Pan, Liu, Yang, Wang, Yin · 2020 · Nanomedicine: Nanotechnology, Biology and Medicine
45. Redox regulation of cancer stem cells: Biology and therapeutic implications
    Min Du, Jian Zhang, Max S. Wicha, Ming Luo · 2024 · MedComm – Oncology
46. HIF factors cooperate with PML‐RARα to promote acute promyelocytic leukemia progression and relapse
    Nadia Coltella, Stefano Percio, Roberta Valsecchi, Roberto Cuttano, Jlenia Guarnerio, Maurilio Ponzoni, Pier Paolo Pandolfi, Giovanni Melillo, Linda Pattini, Rosa Bernardi · 2014 · EMBO Molecular Medicine
47. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells
    Koki Maeda, Qiang Ding, Makoto Yoshimitsu, Taisaku Kuwahata, Yumi Miyazaki, Koichirou Tsukasa, Tomomi Hayashi, Hiroyuki Shinchi, Shoji Natsugoe, Sonshin Takao · 2016 · International Journal of Molecular Sciences
48. Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells
    Haitao Zhu, Lirong Zhang, Yanfang Liu, Yuepeng Zhou, Kang Wang, Xiaodong Xie, Lian Song, Dongqing Wang, Chunlei Han, Qiu‐Yun Chen · 2016 · Scientific Reports
49. Triptolide, a Chinese Herbal Extract, Enhances Drug Sensitivity of Resistant Myeloid Leukemia Cell Lines Through Downregulation of HIF-1α and Nrf2
    Feili Chen, Yuejian Liu, Shiyun Wang, Xutao Guo, Pengcheng Shi, Weiguang Wang, Bing Xu · 2013 · Pharmacogenomics
50. Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)
    Hyun Seung Ban, Yoshikazu Uto, Misun Won, Hiroyuki Nakamura · 2016 · Expert Opinion on Therapeutic Patents
51. Generation of erythroid cells from polyploid giant cancer cells: re-thinking about tumor blood supply
    Zhigang Yang, Hong Yao, Fei Fei, Yu-Wei Li, J. Qu, Chunyuan Li, Shi-Wu Zhang · 2018 · Journal of Cancer Research and Clinical Oncology
52. The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities
    Samantha Bruno, Manuela Mancini, Sara De Santis, Cecilia Monaldi, Michèle Cavo, Simona Soverini · 2021 · International Journal of Molecular Sciences
53. The interferon-inducible protein viperin controls cancer metabolic reprogramming to enhance cancer progression
    Kyung Mi Choi, Jeong Jin Kim, Jihye Yoo, Ku Sul Kim, Youngeun Gu, John Eom, Haengdueng Jeong, Kyungeun Kim, Ki Taek Nam, Young Soo Park et al. · 2022 · Journal of Clinical Investigation
54. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer
    Natividad Gomez-Roman, Neha M. Sahasrabudhe, Fiona McGregor, Anthony J. Chalmers, Jim Cassidy, Jane A. Plumb · 2016 · Oncotarget
55. HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cells
    Albertus T.J. Wierenga, Alan Cunningham, Ayşegül Erdem, Nuria Vilaplana‐Lopera, Annet Z. Brouwers-Vos, Maurien G. M. Pruis, André B. Mulder, Ulrich L. Günther, Joost H.A. Martens, Edo Vellenga et al. · 2019 · Cancer & Metabolism
56. Bacteriotherapy in gastrointestinal cancer
    Saman Soleimanpour, Seyed Mahdi Hasanian, Amir Avan, Atieh Yaghoubi, Majid Khazaei · 2020 · Life Sciences
57. The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia
    Hannah Lawson, James P. Holt‐Martyn, Vilma Dembitz, Yuka Kabayama, Lydia M. Wang, Aarushi Bellani, Samanpreet Atwal, Nadia Saffoon, Jozef Durko, Louie N. van de Lagemaat et al. · 2024 · Nature Cancer
58. Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells
    Steven Mitchell Kornblau, Amina Ann Qutub, Hui Yao, Heather York, Yi Hua Qiu, David Graber, Farhad Ravandi, Jörge E. Cortes, Michael Andreeff, Nianxiang Zhang et al. · 2013 · PLoS ONE
59. Transcription factors: Time to deliver
    Alexey V. Ulasov, Andrey A. Rosenkranz, Alexander S. Sobolev · 2017 · Journal of Controlled Release
60. The Hypoxia-Inducible Factor–C/EBPα Axis Controls Ethanol-Mediated Hepcidin Repression
    Erik R. Anderson, Matthew J. Taylor, Xiang Xue, Angelical S. Martin, David S. Moons, M. Bishr Omary, Yatrik Madhukar Shah · 2012 · Molecular and Cellular Biology
61. Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
    Burslem, George M., Kyle, Hannah F., Nelson, Adam, Edwards, Thomas A., Wilson, Andrew J. · 2017 · Chemical Science
62. Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia
    Alfonso Quintás‐Cardama, Nianxiang Zhang, Yi Hua Qiu, Sean M. Post, Chad J. Creighton, Jörge E. Cortes, Kevin R. Coombes, Steven Mitchell Kornblau · 2014 · Clinical Lymphoma Myeloma & Leukemia
63. Assessment of Hypoxia Inducible Factor Levels in Cancer Cell Lines upon Hypoxic Induction Using a Novel Reporter Construct
    Wenyu Zhou, Timothy L. Dosey, Travis L. Biechele, Randall T. Moon, Marshall S. Horwitz, Hannele Ruohola‐Baker · 2011 · PLoS ONE
64. Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia
    Hui Fang Zhou, Yuelong Jiang, Yuetin Huang, Mengya Zhong, Dongmei Qin, Chendi Xie, Guangchao Pan, Jinshui Tan, Manman Deng, Haijun Zhao et al. · 2022 · Cancer Letters
65. DT-13 attenuates human lung cancer metastasis via regulating NMIIA activity under hypoxia condition
    Xiaohui Wei, Sensen Lin, Yang Liu, Renping Zhao, Ghulam Jilany Khan, Hongzhi Du, Tingting Mao, Boyang Yu, Ruiming Li, Shengtao Yuan et al. · 2016 · Oncology Reports
66. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy
    Jia Li, Wanlin Xi, Xiaofang Li, Haiying Sun, Yuyan Li · 2019 · Bioorganic & Medicinal Chemistry
67. Metabolic Rewiring in Response to Biguanides Is Mediated by mROS/HIF-1a in Malignant Lymphocytes
    Hamidullah Khan, Ashish Anshu, A. Krishna Prasad, Sushmita Roy, Justin J. Jeffery, Wasakorn Kittipongdaja, David T. Yang, Stefan M. Schieke · 2019 · Cell Reports
68. Targeting pancreatic cancer stem cells for cancer therapy
    Jun Xia, Changjie Chen, Zhiwen Chen, Lucio Miele, Fazlul H. Sarkar, Zhiwei Peter Wang · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
69. Catalase‐Functionalized Iron Oxide Nanoparticles Reverse Hypoxia‐Induced Chemotherapeutic Resistance
    Tin‐Yo Yen, Zachary R. Stephen, Guanyou Lin, Qingxin Mu, Mike Jeon, Stela Untoro, Parker Welsh, Miqin Zhang · 2019 · Advanced Healthcare Materials
70. HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia
    Amina M Abdul-Aziz, Manar S. Shafat, Yu Sun, Christopher Richard Marlein, Rachel E. Piddock, Stephen David Robinson, Dylan R. Edwards, Zhigang Zhou, Angela Collins, Kristian M. Bowles et al. · 2018 · Oncogene
71. Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
    Wang, Yin, Liu, Yan, Bailey, Christopher, Zhang, Huixia, He, Miao, Sun, Duxin, Zhang, Peng, Parkin, Brian, Baer, Maria R., Zheng, Pan et al. · 2020 · Oncogene
72. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies
    Joaquín Araos Henríquez, Jonathan Paul Sleeman, Boyan K. Garvalov · 2018 · Clinical & Experimental Metastasis
73. Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumor
    Hyo Jin Kang, Yong Weon Yi, Shujie Hou, Hee Jeong Kim, Yali Kong, Insoo Bae, Milton L. Brown · 2015 · Oncotarget
74. Pleiotropic roles of Notch signaling in normal, malignant, and developmental hematopoiesis in the human
    Rahul Kushwah, Borhane Guezguez, Jung Bok Lee, Claudia I. Hopkins, Mickie Bhatia · 2014 · EMBO Reports
75. Echinomycin inhibits adipogenesis in 3T3-L1 cells in a HIF-independent manner
    Junna Yamaguchi, Tetsuhiro Tanaka, Hisako Saito, Seitaro Nomura, Hiroyuki Aburatani, Hironori Waki, Takashi Kadowaki, Masaomi Nangaku · 2017 · Scientific Reports
76. Loss of ATF4 leads to functional aging-like attrition of adult hematopoietic stem cells
    Yan Sun, Xiaoli Lin, Bangdong Liu, Ya-Xuan Zhang, Wei Li, Shenmin Zhang, Falian He, H. Tian, Xun Zhu, Xi-Meng Liu et al. · 2021 · Science Advances
77. Effects of surgery on the cancer stem cell niche
    Daire O’Leary, E. O'Leary, N. Foley, Thomas G. Cotter, J.H. Wang, Henry Paul Redmond · 2016 · European Journal of Surgical Oncology
78. The hypoxia signalling pathway in haematological malignancies
    Marta Irigoyen, Juan Carlos García‐Ruiz, Edurne Berra · 2017 · Oncotarget
79. Bacteriotherapy in Breast Cancer
    Atieh Yaghoubi, Majid Khazaei, Seyed Mahdi Hasanian, Amir Avan, William Chi Shing Cho, Saman Soleimanpour · 2019 · International Journal of Molecular Sciences
80. HIF-1 Dimerization Inhibitor Acriflavine Enhances Antitumor Activity of Sunitinib in Breast Cancer Model
    Tao Yin, Sisi He, Guobo Shen, Yongsheng Wang · 2015 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
81. Breakthrough science: hypoxia-inducible factors, oxygen sensing, and disorders of hematopoiesis
    Gregg L. Semenza · 2021 · Blood
82. Repression of Zeb1 and Hypoxia Cause Sequential Mesenchymal-to-Epithelial Transition and Induction of Aid, Oct4, and Dnmt1, Leading to Immortalization and Multipotential Reprogramming of Fibroblasts in Spheres
    Yongqing Liu, Partha Mukhopadhyay, Marina Pisano, Xiaoqin Lu, Li Feng Huang, Qingxian Lu, Douglas C. Dean · 2013 · Stem Cells
83. Concise Review: Genetic Dissection of Hypoxia Signaling Pathways in Normal and Leukemic Stem Cells
    Deniz Gezer, Milica Vukovic, Tomoyoshi Soga, Patrick J. Pollard, Kamil R. Kranc · 2014 · Stem Cells
84. Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop
    Lucine Fahy, Julien Calvo, Sara Chabi, Laurent Renou, Charly Le Maout, Sandrine Poglio, Thierry M Leblanc, Arnaud Petit, André Baruchel, Paola Fabiola Ballerini et al. · 2021 · Blood Advances
85. Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cells
    Haojian Zhang, Shaoguang Li · 2013 · Protein & Cell
86. KLF2 inhibits cell growth via regulating HIF-1α/Notch-1 signal pathway in human colorectal cancer HCT116 cells
    Hai-Gang Wang, Bin Cao, Zhang Li-xian, Nan Song, Hui Li, Wen-zeng Zhao, Yanshu Li, Shunmao Ma, Dong-Jian Yin · 2017 · Oncology Reports
87. Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies
    Hanyun Zhang, Chunjie Sun, Qi Sun, Li Ye, Chao Zhou, Changgang Sun · 2023 · Frontiers in Molecular Biosciences
88. Targeting Cancer Stem Cells with Natural Products
    Joseph Burnett, Bryan W. Newman, Duxin Sun · 2012 · Current Drug Targets
89. Integration of hypoxic HIF-α signaling in blood cancers
    Luana Schito, Sergio Rey, Marina Y Konopleva · 2017 · Oncogene
90. Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
    Lappano, Rosamaria, Todd, Lauren A., Stanic, Mia, Cai, Qi, Maggiolini, Marcello, Marincola, Francesco, Pietrobon, Violena · 2022 · Cancers
91. Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
    Martín Villalba, Nuria López-Royuela, Ewelina Krzywińska, Moeez Ghani Rathore, Robert A. Hipskind, Houda Haouas, Nerea Allende-Vega · 2014 · Anti-Cancer Agents in Medicinal Chemistry
92. Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment
    Rawan Nehme, Rawan Hallal, Maya El Dor, Firas H. Kobeissy, Fabrice Gouilleux, Frédéric Mazurier, Kazem Zibara · 2020 · Current Medicinal Chemistry
93. HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development
    Dzhuliia Sh. Dzhalilova, Olga V. Makarova · 2021 · Biochemistry (Moscow)
94. HIF-1α Affects the Neural Stem Cell Differentiation of Human Induced Pluripotent Stem Cells via MFN2-Mediated Wnt/β-Catenin Signaling
    Peng Cui, Ping Zhang, Lin Yuan, Li Wang, Xin Guo, Guanghui Cui, Yanmin Zhang, Minghua Li, Xiaowei Zhang, Xiaoqiang Li et al. · 2021 · Frontiers in Cell and Developmental Biology · Retracted
95. RETRACTED ARTICLE: Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma
    Joo-Yun Byun, Kun Huang, Jong Suk Lee, Wenjie Huang, Li Hu, Xuyu Zheng, Xin Tang, Fengzeng Li, Dong‐Gyu Jo, Xinmao Song et al. · 2022 · Oncogene · Retracted
96. Hypoxia Promotes Dissemination and Colonization in New Bone Marrow Niches in Waldenström Macroglobulinemia
    Barbara Muz, Pilar de la Puente, Feda Azab · 2014 · Molecular Cancer Research
97. CITED2 and the modulation of the hypoxic response in cancer
    Mónica Teotónio Fernandes, Sofia M. Calado, Leonardo Mendes-Silva, José Bragança · 2020 · World Journal of Clinical Oncology
98. HIF‐1α and HSP90: Target molecules selected from a tumorigenic papillary thyroid carcinoma cell line
    Ji‐Hun Mo, Ik Joon Choi, Woo‐Jin Jeong, Eun-Hui Jeon, Soon‐Hyun Ahn · 2011 · Cancer Science
99. Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells
    Peng‐Chan Lin, Hao-Yu Hsieh, Po‐Chen Chu, Ching‐Shiun Chen · 2018 · International Journal of Molecular Sciences
100. Enigmas of IDH mutations in hematology/oncology
     Michael Heuser, Michelle Maria Araujo Cruz, Ramya Goparaju, Anuhar Chaturvedi · 2015 · Experimental Hematology